We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$496M
AUM Growth
+$22M
Cap. Flow
+$34.5M
Cap. Flow %
6.96%
Top 10 Hldgs %
10.47%
Holding
461
New
27
Increased
142
Reduced
189
Closed
26

Sector Composition

Rank Sector Weight
1 Financials 24.1%
2 Real Estate 16.28%
3 Energy 14.42%
4 Healthcare 8.59%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
276
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$151K 0.03%
20,197
-1,125
-5% -$10.8K
KALV
277
DELISTED
KalVista Pharmaceuticals
KALV
$147K 0.03%
12,688
-707
-5% -$11.4K
QURE icon
278
uniQure
QURE
$2.67B
$137K 0.03%
3,476
-194
-5% -$11.2K
PRQR icon
279
ProQR Therapeutics
PRQR
$247M
$132K 0.03%
22,938
-1,278
-5% -$10.2K
ADVM
280
DELISTED
Adverum Biotechnologies
ADVM
$127K 0.03%
2,335
-130
-5% -$14.7K
ANAB icon
281
AnaptysBio
ANAB
$1.61B
$127K 0.03%
3,620
-202
-5% -$9.61K
MSFT icon
282
Microsoft
MSFT
$2.92T
$120K 0.02%
861
+286
+50% +$39.3K
ABEO icon
283
Abeona Therapeutics
ABEO
$352M
$110K 0.02%
1,955
-109
-5% -$8.16K
BABA icon
284
Alibaba
BABA
$274B
$98K 0.02%
588
-554
-49% -$95.2K
CBIO
285
Crescent Biopharma
CBIO
$642M
$97K 0.02%
226
-12
-5% -$7.72K
PHAS
286
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$91K 0.02%
21,738
-1,211
-5% -$9.66K
BAC icon
287
Bank of America
BAC
$438B
$66K 0.01%
2,250
-171
-7% -$4.92K
VZ icon
288
Verizon
VZ
$198B
$62K 0.01%
1,026
AXP icon
289
American Express
AXP
$228B
$46K 0.01%
385
LMT icon
290
Lockheed Martin
LMT
$134B
$46K 0.01%
119
ITUB icon
291
Itaú Unibanco
ITUB
$91.8B
$45K 0.01%
7,278
+1,034
+17% +$6.71K
ELV icon
292
Elevance Health
ELV
$81.7B
$42K 0.01%
175
MRK icon
293
Merck
MRK
$326B
$41K 0.01%
+511
New +$41K
SNPS icon
294
Synopsys
SNPS
$74.6B
$41K 0.01%
301
+38
+14% +$5.14K
PGR icon
295
Progressive
PGR
$126B
$40K 0.01%
513
-250
-33% -$19.7K
PYPL icon
296
PayPal
PYPL
$49.8B
$40K 0.01%
389
+205
+111% +$22.6K
RTX icon
297
RTX Corp
RTX
$295B
$40K 0.01%
462
SBUX icon
298
Starbucks
SBUX
$119B
$40K 0.01%
448
-53
-11% -$4.91K
AMX icon
299
America Movil
AMX
$78B
$38K 0.01%
2,578
-2,725
-51% -$39.1K
VEEV icon
300
Veeva Systems
VEEV
$31.7B
$38K 0.01%
251

Similar funds

Virtus ETF Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Virtus ETF Advisers held 461 positions worth $496M, up 4.6% from $474M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Virtus ETF Advisers deployed $34.5M of net new capital in Q3 2019, opening 27 new positions and adding to 142 existing holdings. Its largest new stake was INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND: 287,315 shares worth $3.16M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was TriplePoint Venture Growth BDC, an estimated $813K trimmed.

  • Virtus ETF Advisers's largest Q3 2019 buy was INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND: 287,315 shares worth $3.16M.
  • Virtus ETF Advisers added most to MPLX in Q3 2019, an estimated $3.04M increase.
  • Virtus ETF Advisers's biggest Q3 2019 reduction was TriplePoint Venture Growth BDC, cutting an estimated $813K.
  • Virtus ETF Advisers fully exited Oxford Lane Capital in Q3 2019, selling an estimated $6.67M.
  • Virtus ETF Advisers's ten largest holdings make up 10% of its $496M portfolio in Q3 2019.
  • Virtus ETF Advisers opened 27 new positions and closed 26 in Q3 2019.
  • Virtus ETF Advisers's portfolio value rose 4.6% quarter-over-quarter to $496M.

Based on Virtus ETF Advisers's 13F filing for Q3 2019, filed 12 Nov 2019.